About this trial
Individual overexpression of the three miRNAs negatively affects cell viability and proliferation mainly in grade III IDH-wild type cells, while in higher grade cells, the effect is more pronounced when the entire signature is overexpressed, individual and combined overexpression of the signature members is able to determine a significant reduction in both migration and invasion. Therefore, ectopic expression of the miRNAs identified by us has a negative impact on cell viability, proliferation and apoptosis, but above all on migration and invasion.
Eligibility criteria
Qualifiers
histological diagnosis of glioma;
no concomitant primary tumor;
no metastatic disease;
availability of surgical material/tissue;
Disqualifiers
histological diagnosis of non-glial tumor;
patients with concomitant other solid tumors;
metastatic disease;
no surgical material/tissue available;
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Regina Elena Cancer Institute
Lead sponsor
University of Roma La Sapienza
Collaborator
San Camillo Hospital, Rome
Collaborator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Collaborator
Neuromed IRCCS
Collaborator